Alembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 16891.65 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 30-06-2021, the company reported a Consolidated Total Income of Rs 1327.91 Crore, up 3.39 % from last quarter Total Income of Rs 1284.34 Crore and down -1.02 % from last year same quarter Total Income of Rs 1341.64 Crore. Company reported net profit after tax of Rs 148.35 Crore in latest quarter.
Investment Rationale
The benefits of a meaningful investment in product development as well as R&D towards Injectables are getting prolonged due to ongoing COVID-related travel restrictions on inspections. The brokerage maintains Neutral rating on limited upside from current levels.
Promoter/FII Holdings
Promoters held 69.5 per cent stake in the company as of June 30, 2021, while FIIs held 6.4 per cent, DIIs 11.3 per cent and public and others 12.9 per cent.
(Disclaimer: Views and recommendations given in this section are the analysts’ own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.
